• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微流成像:嵌套统计分析估计关键因素对亚可见粒子计数测量变异性的贡献。

Micro-Flow Imaging: Estimation of the Contribution of Key Factors to the Variability of Subvisible Particle Count Measurement by a Nested Statistical Analysis.

机构信息

Departments of BioPharmaceutical Product Sciences and.

Statistics and Programming, GlaxoSmithKline Inc., 1250 S Collegeville Road, Collegeville, PA 19426.

出版信息

PDA J Pharm Sci Technol. 2020 Jan-Feb;74(1):15-26. doi: 10.5731/pdajpst.2018.009324. Epub 2019 Sep 13.

DOI:10.5731/pdajpst.2018.009324
PMID:31519785
Abstract

Understanding the contribution of relevant factors to the analytical variability of the micro-flow imaging (MFI) technique is of prime importance because of the significance of the subvisible particulate data in biopharmaceutical product development. The current study was performed to determine the contribution of several key variables to the variability of the subvisible particle counts (e.g., day-to-day, vial-to-vial, sample-to-sample, and measurement-to-measurement variabilities) using a nested statistical analysis. The variability was measured in the <10 μm, ≥10 μm, ≥25 μm, and ≥50 μm size ranges along with the total particle count and the maximum and the mean particle size. The contribution of the vial to the variability of the subvisible particle counts was found to be greater than those of the other factors evaluated in the current study. The analytical method variability in terms of percent relative standard deviation with respect to the particle count in the <10 μm, ≥10 μm, and ≥25 μm size ranges was found to be 16%, 40%, and 44%, respectively. A thorough understanding of the contribution of key factors to the analytical variability revealed how the corresponding contribution can be minimized, that is, by increasing the number of vials, samples, and measurements. The results of the current study may be leveraged for the optimization of the analytical method or for minimization of the analytical variability with the MFI technique.

摘要

了解相关因素对微流成像(MFI)技术分析变异性的贡献至关重要,因为亚可见颗粒数据在生物制药产品开发中具有重要意义。本研究采用嵌套式统计分析,旨在确定几个关键变量对亚可见颗粒计数(例如,日-日、瓶-瓶、样品-样品和测量-测量变异性)的变异性的贡献。在<10μm、≥10μm、≥25μm 和≥50μm 粒径范围内以及总颗粒计数、最大和平均粒径来测量变异性。结果表明,与当前研究中评估的其他因素相比,瓶对亚可见颗粒计数变异性的贡献更大。在<10μm、≥10μm 和≥25μm 粒径范围内,分析方法变异性(以相对于<10μm 粒径范围内颗粒计数的百分比相对标准偏差表示)分别为 16%、40%和 44%。深入了解关键因素对分析变异性的贡献,可以揭示如何通过增加瓶数、样品数和测量数来最小化相应的贡献。本研究的结果可用于优化分析方法或最小化 MFI 技术的分析变异性。

相似文献

1
Micro-Flow Imaging: Estimation of the Contribution of Key Factors to the Variability of Subvisible Particle Count Measurement by a Nested Statistical Analysis.微流成像:嵌套统计分析估计关键因素对亚可见粒子计数测量变异性的贡献。
PDA J Pharm Sci Technol. 2020 Jan-Feb;74(1):15-26. doi: 10.5731/pdajpst.2018.009324. Epub 2019 Sep 13.
2
Subvisible (2-100 μm) particle analysis during biotherapeutic drug product development: Part 2, experience with the application of subvisible particle analysis.生物治疗药物产品研发过程中的亚可见(2 - 100微米)颗粒分析:第2部分,亚可见颗粒分析应用经验
Biologicals. 2015 Nov;43(6):457-73. doi: 10.1016/j.biologicals.2015.07.011. Epub 2015 Aug 29.
3
Factors Governing the Accuracy of Subvisible Particle Counting Methods.亚可见颗粒计数方法准确性的影响因素。
J Pharm Sci. 2016 Jul;105(7):2042-52. doi: 10.1016/j.xphs.2016.03.044. Epub 2016 Jun 8.
4
Unmasking translucent protein particles by improved micro-flow imaging™ algorithms.通过改进的微流成像™算法揭示半透明蛋白质颗粒。
J Pharm Sci. 2014 Jan;103(1):107-14. doi: 10.1002/jps.23786. Epub 2013 Nov 26.
5
Calculating the mass of subvisible protein particles with improved accuracy using microflow imaging data.利用微流成像数据更精确地计算亚可见蛋白质颗粒的质量。
J Pharm Sci. 2015 Feb;104(2):536-47. doi: 10.1002/jps.24156. Epub 2014 Oct 9.
6
Label-free flow cytometry analysis of subvisible aggregates in liquid IgG1 antibody formulations.液体IgG1抗体制剂中亚可见聚集体的无标记流式细胞术分析
J Pharm Sci. 2014 Jan;103(1):90-9. doi: 10.1002/jps.23782. Epub 2013 Nov 11.
7
Processing Impact on Monoclonal Antibody Drug Products: Protein Subvisible Particulate Formation Induced by Grinding Stress.加工对单克隆抗体药物产品的影响:研磨应力诱导的蛋白质亚可见颗粒形成
PDA J Pharm Sci Technol. 2017 May-Jun;71(3):172-188. doi: 10.5731/pdajpst.2016.006726. Epub 2016 Oct 27.
8
Closing the Gap: Counting and Sizing of Particles Across Submicron Range by Flow Cytometry in Therapeutic Protein Products.缩小差距:治疗性蛋白产品中超亚微米粒径颗粒的流式细胞计数和粒径分析
J Pharm Sci. 2017 Nov;106(11):3215-3221. doi: 10.1016/j.xphs.2017.06.007. Epub 2017 Jun 15.
9
Comparative Evaluation of Two Methods for Preparative Fractionation of Proteinaceous Subvisible Particles--Differential Centrifugation and FACS.蛋白质亚可见颗粒制备分级分离的两种方法——差速离心法和荧光激活细胞分选法的比较评估
Pharm Res. 2015 Dec;32(12):3952-64. doi: 10.1007/s11095-015-1755-6. Epub 2015 Jul 21.
10
Measurement of subvisible particulates in lyophilised Erwinia chrysanthemi L-asparaginase and relationship with clinical experience.测定冷冻干燥的欧文氏菌属 L-天冬酰胺酶中的亚可见颗粒与临床经验的关系。
AAPS J. 2014 Jul;16(4):784-90. doi: 10.1208/s12248-014-9612-9. Epub 2014 May 23.